NCT00947843View on ClinicalTrials.gov

Efficacy and Tolerability of Clopidogrel Resinate and Clopidogrel Bisulfate in Patients With Coronary Heart Disease (CHD) or CHD Equivalents

PHASE4CompletedINTERVENTIONAL
Enrollment

306

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions
Coronary Heart Disease
Interventions
DRUG

aspirin + pregrel (Clopidogrel resinate)

DRUG

aspirin + placebo

DRUG

aspirin + plavix (Clopidogrel bisulfate)

Sponsors
All Listed Sponsors
collaborator

CKD Pharmaceutical Limited

UNKNOWN

lead

Seoul National University Hospital

OTHER

NCT00947843 - Efficacy and Tolerability of Clopidogrel Resinate and Clopidogrel Bisulfate in Patients With Coronary Heart Disease (CHD) or CHD Equivalents | Biotech Hunter | Biotech Hunter